Atlas Trials

Modulation of Response to Hormonal Therapy With Lapatinib and/or Metformin in Patients With Metastatic Breast Cancer

Clinical trial NCT01477060 · TERMINATED

Trial details

NCT number
NCT01477060
Sponsor
Fondazione Michelangelo
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2011-11-01
Primary completion
2013-12-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.